Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline - PubMed (original) (raw)
Practice Guideline
. 2018 Sep 1;36(25):2647-2655.
doi: 10.1200/JCO.2018.79.2721. Epub 2018 Jun 11.
Heather Greenlee 1, Kari Bohlke 1, Ting Bao 1, Angela M DeMichele 1, Gary E Deng 1, Judith M Fouladbakhsh 1, Brigitte Gil 1, Dawn L Hershman 1, Sami Mansfield 1, Dawn M Mussallem 1, Karen M Mustian 1, Erin Price 1, Susan Rafte 1, Lorenzo Cohen 1
Affiliations
- PMID: 29889605
- DOI: 10.1200/JCO.2018.79.2721
Practice Guideline
Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline
Gary H Lyman et al. J Clin Oncol. 2018.
Abstract
Purpose The Society for Integrative Oncology (SIO) produced an evidence-based guideline on use of integrative therapies during and after breast cancer treatment that was determined to be relevant to the American Society of Clinical Oncology (ASCO) membership. ASCO considered the guideline for endorsement. Methods The SIO guideline addressed the use of integrative therapies for the management of symptoms and adverse effects, such as anxiety and stress, mood disorders, fatigue, quality of life, chemotherapy-induced nausea and vomiting, lymphedema, chemotherapy-induced peripheral neuropathy, pain, and sleep disturbance. Interventions of interest included mind and body practices, natural products, and lifestyle modifications. SIO systematic reviews focused on randomized controlled trials that were published from 1990 through 2015. The SIO guideline was reviewed by ASCO content experts for clinical accuracy and by ASCO methodologists for developmental rigor. On favorable review, an ASCO Expert Panel was convened to review the guideline contents and recommendations. Results The ASCO Expert Panel determined that the recommendations in the SIO guideline-published in 2017-are clear, thorough, and based on the most relevant scientific evidence. ASCO endorsed the guideline with a few added discussion points. Recommendations Key recommendations include the following: Music therapy, meditation, stress management, and yoga are recommended for anxiety/stress reduction. Meditation, relaxation, yoga, massage, and music therapy are recommended for depression/mood disorders. Meditation and yoga are recommended to improve quality of life. Acupressure and acupuncture are recommended for reducing chemotherapy-induced nausea and vomiting. Acetyl-l-carnitine is not recommended to prevent chemotherapy-induced peripheral neuropathy because of a possibility of harm. No strong evidence supports the use of ingested dietary supplements to manage breast cancer treatment-related adverse effects. Additional information is available at: www.asco.org/supportive-care-guidelines .
Similar articles
- Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.
Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, Johnson JA, Mumber M, Seely D, Zick SM, Boyce LM, Tripathy D. Greenlee H, et al. CA Cancer J Clin. 2017 May 6;67(3):194-232. doi: 10.3322/caac.21397. Epub 2017 Apr 24. CA Cancer J Clin. 2017. PMID: 28436999 Free PMC article. Review. - Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Quon H, Vapiwala N, Forastiere A, Kennedy EB, Adelstein DJ, Boykin H, Califano JA, Holsinger FC, Nussenbaum B, Rosenthal DI, Siu LL, Waldron JN. Quon H, et al. J Clin Oncol. 2017 Dec 20;35(36):4078-4090. doi: 10.1200/JCO.2017.73.8633. Epub 2017 Oct 24. J Clin Oncol. 2017. PMID: 29064744 - Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults With Cancer: Society for Integrative Oncology-ASCO Guideline.
Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG, Bradt J, Fuller-Shavel N, Goodman J, Hoffman CJ, Huston A, Mehta A, Paller CJ, Richardson K, Seely D, Siwik CJ, Temel JS, Rowland JH. Carlson LE, et al. J Clin Oncol. 2023 Oct 1;41(28):4562-4591. doi: 10.1200/JCO.23.00857. Epub 2023 Aug 15. J Clin Oncol. 2023. PMID: 37582238 Review. - Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.
Greenlee H, Balneaves LG, Carlson LE, Cohen M, Deng G, Hershman D, Mumber M, Perlmutter J, Seely D, Sen A, Zick SM, Tripathy D; Society for Integrative Oncology. Greenlee H, et al. J Natl Cancer Inst Monogr. 2014 Nov;2014(50):346-58. doi: 10.1093/jncimonographs/lgu041. J Natl Cancer Inst Monogr. 2014. PMID: 25749602 Free PMC article. Review. - Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Bezjak A, Temin S, Franklin G, Giaccone G, Govindan R, Johnson ML, Rimner A, Schneider BJ, Strawn J, Azzoli CG. Bezjak A, et al. J Clin Oncol. 2015 Jun 20;33(18):2100-5. doi: 10.1200/JCO.2014.59.2360. Epub 2015 May 5. J Clin Oncol. 2015. PMID: 25944914
Cited by
- Enhancing patient activation: a controlled implementation study of an interprofessional evidence-based counseling program for complementary and integrative healthcare in cancer patients ('CCC-Integrativ').
Valentini J, Froehlich D, Roesel I, Stolz R, Mahler C, Martus P, Klafke N, Horneber M, Witte C, Kramer K, Greil C, Gruen B, Tomaschko-Ubelaender K, Joos S; CCC-Integrativ Study Group. Valentini J, et al. Front Med. 2024 Nov 14. doi: 10.1007/s11684-024-1097-z. Online ahead of print. Front Med. 2024. PMID: 39542987 - Frequency and Characteristics of Integrative Oncology Referrals for Patients With Cancer Receiving Inpatient Rehabilitation.
Gupta E, Lopez G, Narayanan S, Tennison JM, Elahi I, Rozman de Moraes A, Fellman BM, Bruera E. Gupta E, et al. Integr Cancer Ther. 2024 Jan-Dec;23:15347354241296810. doi: 10.1177/15347354241296810. Integr Cancer Ther. 2024. PMID: 39498495 Free PMC article. - An Internet Mantram Repetition Program to Promote Well-being in Breast Cancer Survivors: A Feasibility Randomized Controlled Trial.
Hulett JM, Cheng AL, Bormann JE, Anbari AB, Armer JM, Hartman BM, Ann Bettencourt B, Sherwin LB, Sperling EL, Narkthong N, Reinero C, Rindt H, Schreiber K, Peterson LL, Albright E. Hulett JM, et al. Integr Cancer Ther. 2024 Jan-Dec;23:15347354241290504. doi: 10.1177/15347354241290504. Integr Cancer Ther. 2024. PMID: 39427264 Free PMC article. Clinical Trial. - Breast Cancer and Risk of Depression: A Comparative Cross-Sectional Study Among Women With and Without Breast Cancer in Addis Ababa, Ethiopia.
Gebremariam A, Addissie A, Dereje N, Assefa M, Jemal A. Gebremariam A, et al. JCO Glob Oncol. 2024 Oct;10:e2400235. doi: 10.1200/GO.24.00235. Epub 2024 Oct 10. JCO Glob Oncol. 2024. PMID: 39388658 Free PMC article. - Results of the Italian cross-sectional web-based survey "Nutrition and breast cancer, what would you like to know?" An attempt to collect and respond to patients' information needs, through social media.
Caprara G, Pagan E, Titta L, Tieri M, Magionesi G, Gallosti S, Bagnardi V, Mazzocco K, Mazza M. Caprara G, et al. Front Oncol. 2024 Sep 25;14:1436610. doi: 10.3389/fonc.2024.1436610. eCollection 2024. Front Oncol. 2024. PMID: 39386191 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical